1) Denny L, Quinn M, Sankaranarayanan R : Chapter 8 : Screening for cervical cancer in developing countries. Vaccine 24(Suppl3):71-77,2006
2) Wright TC Jr, Schiffman M : Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med 348:489-490,2003
3) Cervix Cancer Screening-IARC Handbooks of Cancer Prevention Vol.10, IARC Press, Lyon,pp122-211,2005
4) van Ballegooijen M, van den Akker-van Marle E, Patnick J, et al : Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 36:2177-2188,2000
5) Sasieni P, Adams J, Cuzick J, et al : Benefit of cervical screening at different ages : evidence from the UK audit of screening histories. Br J Cancer 89:88-93,2003
6) Sawaya GF, McConnell KJ, Kulasingam SL, et al : Risk of cervical cancer associated with extending the interval between cervical-caner screenings. N Engl J Med 349:1501-1509,2003
7) Patnick J : Cervical cancer screening in England. Eur J Cancer 36:2205-2208,2000
8) Wright TC Jr, Schiffman M, Solomon D, et al : Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 103:304-309,2004
9) Wright TC Jr, Cox JT, Massad LS, et al : 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287:2120-2129,2002
10) Bulkmans NW, Berkhof J, Rozendaal L, et al : Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade3 and cancer : 5-year follow-up of a randomised controlled implementation trial. Lancet 370:1764-1772,2007
11) 今野良,岩成治:HPV DNA検査.化療の領域 27:323-334,2011